Stent Platform
• Fully degradable poly(L-lactide)
• Sine wave structure in space, In-phase peak-valley connection
Drug coating
• Fully degradable poly(D,L-lactide)
• Effectively control sirolimus release rate
• Classical Sirolimus with dose of 15.3ug/mm
• Inhibit the proliferation and migration of smooth muscle cells
Delivery system
• Completely self-developed second-generation rapid-exchange balloon dilatation catheter
• Superior pushability and crossability
Sirolimus-eluting Bioresorbable Coronary Stent System
Ordering Information
Compliance Chart